Skip to content
Upcoming events
AEEDC Dubai 202719–21 January 2027World Health Expo (WHX) Dubai 202725–28 January 2027ChinaDental South China 20273–6 March 2027GermanyIDS 2027 — International Dental Show16–20 March 2027United StatesAAD Annual Meeting 202719–23 March 2027Dubai Derma 20276–8 April 2027Dental-Expo Moscow Spring 202726–29 April 2027France7th World Congress of Dermoscopy12–15 May 2027GermanyEADV Symposium 202720–22 May 2027United StatesASCO Annual Meeting 20274–8 June 2027ChinaSino-Dental 20279–12 June 2027White Nights 2027 — St. Petersburg International Oncology ForumUsually early JulyArmenian Medical World Congress 20278–10 July 2027Dental-Expo Moscow 2027Usually late SeptemberNetherlandsEADV Congress 202722–25 September 2027SpainEAO Congress 202723–25 September 2027CanadaCFAS Annual Meeting 202723–25 September 2027Russian Health Care Week 2027Usually December

Medicine practice question: Pharmacology

Which drug class is first-line for most patients with heart failure with reduced ejection fraction to reduce mortality?

  • A. Loop diuretics alone
  • B. ACE inhibitors or ARNI, beta-blockers, MRAs and SGLT2 inhibitors
  • C. Non-dihydropyridine calcium channel blockers
  • D. Digoxin alone
Show the answer and explanation

Answer: B. ACE inhibitors or ARNI, beta-blockers, MRAs and SGLT2 inhibitors

Guideline-directed therapy for HFrEF combines an ACE inhibitor/ARB or ARNI, an evidence-based beta-blocker, a mineralocorticoid receptor antagonist and an SGLT2 inhibitor. Loop diuretics relieve symptoms but do not reduce mortality.

Test yourself under exam conditions

Take a free timed practice test with a real countdown, instant scoring and a report of your strong and weak topics.

Start the free exam simulator

Original Medsenna practice question written in board style; not an actual exam question.